Madrigal Pharma (MDGL) Misses Q4 EPS by 44c
Madrigal Pharma (NASDAQ: MDGL) reported Q4 EPS of ($5.68), $0.44 worse than the analyst estimate of ($5.24).
For earnings history and earnings-related data on Madrigal Pharma (MDGL) click here.
Madrigal Pharma (NASDAQ: MDGL) reported Q4 EPS of ($5.68), $0.44 worse than the analyst estimate of ($5.24).
For earnings history and earnings-related data on Madrigal Pharma (MDGL) click here.